Sodium Acetate Injection USP; Incorrect GTIN
Brand(s)
Last updated
Summary
Product
Sodium Acetate Injection USP
Issue
Health products - Labelling
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|---|
| Omega Laboratories | Sodium Acetate Injection USP | DIN 02181746 | Solution | Sodium Acetate 328 mg/mL | E112A009R, E112A010R |
Issue
The Global Trade Identification Number (GTIN) coded into the 2D data matrix barcode on the vial of the affected lots is incorrect.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Omega Laboratories Ltd
11177 Rue Hamon,
Montréal, QC H3M 3E4
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-77066
Get notified
Receive notifications for new and updated recalls and alerts by category.